U.S. FDA Licenses ADMET Predictor(TM) from Simulations Plus - Forbes
Jess Garner | August 9, 2008
U.S. FDA Licenses ADMET Predictor(TM) from Simulations Plus - Forbes
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from the U.S. Food and Drug Administration (FDA) to license the Company’s ADMET …
